These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 6499924)

  • 1. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake.
    Richelson E; Pfenning M
    Eur J Pharmacol; 1984 Sep; 104(3-4):277-86. PubMed ID: 6499924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.
    Bolden-Watson C; Richelson E
    Life Sci; 1993; 52(12):1023-9. PubMed ID: 8445992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of in vitro amine uptake into rat brain synaptosomes after in vivo administration of antidepressants.
    Manias B; Taylor DA
    Eur J Pharmacol; 1983 Nov; 95(3-4):305-9. PubMed ID: 6653676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression.
    Randrup A; Braestrup C
    Psychopharmacology (Berl); 1977 Aug; 53(3):309-14. PubMed ID: 408861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines.
    Goodlet I; Mireylees SE; Sugrue MF
    Br J Pharmacol; 1977 Oct; 61(2):307-13. PubMed ID: 922259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mepiprazole, a new psychotropic drug: effects on uptake and retention of monoamines in rat brain synaptosomes.
    Placheta P; Singer E; Kriwanek W; Hertting G
    Psychopharmacology (Berl); 1976 Aug; 48(3):295-301. PubMed ID: 9660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition of monoamine uptake into rat brain synaptosomess by selected bicyclo-octanes and an analogous bicyclo-octene.
    Wedley S; Howard JL; Large BT; Pullar IA
    Biochem Pharmacol; 1978; 27(24):2907-9. PubMed ID: 736983
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain.
    Rothman RB; Katsnelson M; Vu N; Partilla JS; Dersch CM; Blough BE; Baumann MH
    Eur J Pharmacol; 2002 Jun; 447(1):51-7. PubMed ID: 12106802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.
    Xie Z; Westmoreland SV; Miller GM
    J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone inhibits serotonin and norephinephrine uptake into rat brain synaptosomes and synaptic vesicles in vitro but not in vivo.
    Slotkin TA; Seidler FJ; Whitmore WL
    Eur J Pharmacol; 1978 Jun; 49(4):357-62. PubMed ID: 668807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase inhibition and brain amine metabolism after oral treatment with toloxatone in the rat.
    Keane PE; Kan JP; Sontag N; Benedetti MS
    J Pharm Pharmacol; 1979 Nov; 31(11):752-4. PubMed ID: 41906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncompetitive amine uptake inhibition by the new antidepressant pridefine.
    DeMet EM; Vosmer G; Halaris AE
    J Neurochem; 1981 Mar; 36(3):917-23. PubMed ID: 7205281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the antidepressant binodaline on biogenic amine uptake and brain levels in the rat.
    Benfield DP; Luscombe DK
    Arzneimittelforschung; 1983; 33(6):847-50. PubMed ID: 6684438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives.
    Tessel RE; Rutledge CO
    J Pharmacol Exp Ther; 1976 May; 197(2):253-62. PubMed ID: 1271279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of the antidepressant pridefine (AHR-1118) on biogenic amines in the rat brain.
    Vosmer G; DeMet EM; Halaris AE
    Biochem Pharmacol; 1980 Oct; 29(19):2557-62. PubMed ID: 7426062
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of clomipramine and other tricyclic antidepressants on biogenic amine uptake and turnover.
    Waldmeier PC; Baumann P; Greengrass PM; Maître L
    Postgrad Med J; 1976; 52(3 suppl):33-9. PubMed ID: 785423
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of nomifensine (HOE 984), a new antidepressant, on uptake of noradrenaline and serotonin and on release of noradrenaline in rat brain synaptosomes.
    Schacht U; Heptner W
    Biochem Pharmacol; 1974 Dec; 23(24):3413-22. PubMed ID: 4441422
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD; Nichols DE; Yim GK
    Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of viloxazine, its optical isomers and its major metabolites on biogenic amine uptake mechanisms in vitro and in vivo.
    Blackburn TP; Foster GA; Greenwood DT; Howe R
    Eur J Pharmacol; 1978 Dec; 52(3-4):367-74. PubMed ID: 729646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.